Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Leading Edge Pharms announced a distribution deal with MarketHub Retail Services, a distribution network focusing on hemp-based health products.
read more
DaVita Clinical Research® (DCR®), a provider of clinical research services focused on kidney research as well as a multitude of specialty therapeutic populations, has hired four individuals to ignite the expansion of DCR at its latest clinical ...
read more
Wednesday, April 12, 2017
The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI) and SOTIO a.s. have signed a collaboration and license agreement providing SOTIO with exclusive rights to an oncology program addressing a novel target in tumor metabolism. It was ...
read more
LBB Specialties announced the expansion of its distribution partnership with Clariant. This expansion enhances LBBS's presence in Puerto Rico's Life Sciences sector, providing customers with local access to Clariant's pharmaceutical-grade excipients...
read more
Thursday, December 05, 2024
LBB Specialties (LBBS) announced a strategic partnership with Clariant, a provider of specialty chemical manufacturing. Through this collaboration, LBB Specialties will distribute Clariant's pharmaceutical-grade high-functional excipients – including...
read more
CVS Health Corp. deliberately overcharged some pharmacy customers for generic drugs by submitting claims to their insurance companies at inflated prices, according to a lawsuit filed Thursday in federal court in San Francisco.
read more
Tuesday, February 03, 2015
Dr. Satyanarayana Chava, Founder and CEO of Laurus Labs Private Limited, India, today announced that the company has launched Laurus Synthesis Inc., a new U.S. pharmaceutical and biotech services entity. Laurus Synthesis Inc. will operate under the ...
read more
Dr. Parks, currently Senior Vice President of Marketing & Sales for the DSM Pharmaceutical Products business group of Royal DSM N.V. (NYSE, Euronext: DSM KON), has been appointed President and Business Unit Director of DSM Pharmaceuticals, Inc, as of...
read more
LaunchWorks CDMO has been approved to manufacture and distribute Viral Transport Media, in accordance with Section IV.B of the FDA’s COVID-19 Transport Media Policy.
read more
LaunchWorks announced that it has increased its filling capacity for the production of diagnostic test kits with the addition of new automation equipment at its Beverly, MA and Anjou, Canada facilities.
read more
LaunchWorks Manufacturing Lab, a company serving the life science market, is now LaunchWorks CDMO.
read more
Thursday, February 27, 2020
Latham BioPharm Group announced the recent addition of Dr. Thijs Beuming to the team to lead In Silico Drug Discovery services.
read more
Tuesday, January 28, 2025
Lantheus Holdings, Inc. announced a definitive agreement to acquire Evergreen Theragnostics, Inc., in an all-cash transaction consisting of an upfront payment of $250 million and up to an additional $752.5 million in potential milestone payments.
read more
Wednesday, February 13, 2013
Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced that the U.S. Food and Drug Administration (FDA) has granted approval of a Supplemental New Drug ...
read more
Lantheus Holdings has entered into an agreement with NanoMab Technology, a biopharmaceutical company focusing on the development of next generation radiopharmaceuticals to be used in the development of immuno-oncology therapies.
read more